FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
◀ INDEXPEPPUDEX
GHRP-2 trading card

NO. 033 · STAGE 1 · Lv. 70 · HP 125

GHRP-2

Low-Appetite Ghrelin Receptor Agonist · Pralmorelin

REVIEWED BY · PEPPU STUDIO RESEARCH DESK·LAST UPDATED · 2026-05-25
GROWTH

ALIASES

GHRP-2, Pralmorelin, KP102, growth hormone-releasing peptide 2

CLASS

Synthetic hexapeptide · ghrelin receptor agonist

FORMULA

C45H55N9O6

SEQUENCE

D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2

HALF-LIFE

~15-60 minutes

ROUTES

Subcutaneous (research) · Intranasal (Japan diagnostic)

MECHANISM OF ACTION

Hexapeptide ghrelin receptor (GHS-R1a) agonist. Drives pituitary GH release with mild concomitant cortisol and prolactin elevation. Lower appetite stimulation than the structurally related GHRP-6.

EVIDENCE GRADES

GH-secretion diagnostic (human)A

Pralmorelin approved as a diagnostic agent in Japan for GH-deficiency testing. Reliable acute GH-response biomarker.

Selective ghrelin receptor activationA

Well-characterized GHS-R1a binding affinity (Bowers, Smith et al.). Lower appetite signal than the structurally related GHRP-6.

Long-term body composition (human)D

No completed long-term Phase 3 trials for body-composition endpoints.

MECHANISM CATEGORIES

RESEARCH CONDITIONS

SAFETY

Side effects

  • Transient hunger (mild)
  • Mild cortisol elevation
  • Mild prolactin elevation
  • Flushing
  • Injection-site reactions

Known interactions

  • Concurrent rhGH not recommended
  • Glucocorticoids may blunt response

Contraindications

  • Active malignancy
  • Pituitary tumor
  • Pregnancy/lactation

REGULATORY STATUS

FDA · Not FDA-approved. Research-use only in the United States.

WADA · Prohibited at all times under WADA Section S2 (growth-hormone-secretagogue sub-category).

STORAGE

Lyophilized · 4 °C 24 months

Reconstituted · 2-8 °C, 28 days

PEER-REVIEWED EVIDENCE

  • Bowers CY, Reynolds GA, Durham D, et al.. Growth hormone-releasing peptide-2: A diagnostic agent for pediatric GH deficiency. Endocrine 2001. link →
  • Smith RG, Van der Ploeg LH, Howard AD, et al.. Pharmacology and effects of growth hormone-releasing peptides. Endocr Rev 1997. link →

FAQ · 8 QUESTIONS

What is GHRP-2?

GHRP-2 (also called pralmorelin) is a synthetic hexapeptide ghrelin / GHS-R1a receptor agonist that triggers pulsatile GH release from anterior-pituitary somatotrophs. It is approved as a diagnostic agent for GH-deficiency testing in Japan.

GHRP-2 vs GHRP-6 · what's the difference?

Both are hexapeptide ghrelin receptor agonists. GHRP-2 has lower appetite signal than GHRP-6 due to differential downstream signaling at the GHS-R1a. GHRP-2 is preferred where appetite stimulation is unwanted; GHRP-6 is preferred where appetite stimulation is part of the research design.

GHRP-2 vs ipamorelin · which is cleaner?

Ipamorelin is the cleanest in the class (no significant cortisol or prolactin elevation). GHRP-2 produces mild cortisol and prolactin elevation along with the GH pulse. Both are GHS-R1a agonists; ipamorelin's selectivity is the differentiator.

Is GHRP-2 FDA-approved?

Not in the United States. Pralmorelin (the diagnostic formulation) is approved in Japan for GH-deficiency testing.

Is GHRP-2 WADA-prohibited?

Yes. GHRP-2 is prohibited at all times under WADA Section S2 in the growth-hormone-secretagogue sub-category.

What is the half-life of GHRP-2?

Approximately 15-60 minutes plasma half-life. Multiple daily administrations are needed for sustained GH-axis stimulation in research protocols.

How does GHRP-2 work?

GHRP-2 binds the ghrelin receptor (GHS-R1a) on anterior-pituitary somatotrophs and arcuate-nucleus neurons. The pituitary engagement triggers GH release; the hypothalamic engagement produces mild appetite stimulation (less than GHRP-6, more than ipamorelin).

Why is GHRP-2 paired with a GHRH analog?

Ghrelin-receptor activation alone produces a smaller GH pulse than dual-pathway activation. Pairing with a GHRH analog (CJC-1295 No DAC or sermorelin) engages an independent upstream pathway and amplifies the pulse synergistically.

SIGNATURE MOVES

GHS-R BurstPOW 60

Ghrelin receptor activation. Lower appetite signal than GHRP-6.

GH Test PulsePOW 90

Used as a diagnostic GH-secretion test in Japan.

SOURCED FROM PEPPU LABS

Reference compounds documented on this page are available as research-grade material at Peppu Studio · ≥99% purity · per-batch Certificate of Analysis. For laboratory research use only. No human dose is recommended by this wiki.

SOURCE AT PEPPU LABS ▶WIKI ENTRY ▶

▶ LAST UPDATED · 2026-05-25

© 2026 Peppu Studio LLC · For Laboratory Research Use Only